Dusk Group Ltd. (DSK) Receives a Buy from Canaccord Genuity
Confident Investing Starts Here:
Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
According to TipRanks, Franklin is an analyst with an average return of -2.4% and a 35.53% success rate.
Currently, the analyst consensus on Dusk Group Ltd. is a Moderate Buy with an average price target of A$1.60.
DSK market cap is currently A$53.55M and has a P/E ratio of 9.30.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Insider
31 minutes ago
- Business Insider
Tesla (TSLA) Gets a Buy from Piper Sandler
In a report released today, Alexander Potter from Piper Sandler maintained a Buy rating on Tesla, with a price target of $400.00. The company's shares closed last Friday at $302.63. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Potter is a 5-star analyst with an average return of 18.7% and a 47.67% success rate. Potter covers the Consumer Cyclical sector, focusing on stocks such as Tesla, Ford Motor, and Carvana Co. In addition to Piper Sandler, Tesla also received a Buy from Morgan Stanley's Adam Jonas in a report issued today. However, on July 31, Wolfe Research reiterated a Hold rating on Tesla (NASDAQ: TSLA). Based on Tesla's latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $22.5 billion and a net profit of $1.17 billion. In comparison, last year the company earned a revenue of $25.5 billion and had a net profit of $1.4 billion Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of TSLA in relation to earlier this year. Most recently, in June 2025, Xiaotong Zhu, the SVP, APAC of TSLA sold 15,000.00 shares for a total of $4,857,000.00.
Business Insider
2 hours ago
- Business Insider
Evercore ISI Sticks to Their Buy Rating for Amazon (AMZN)
In a report released on August 1, Mark Mahaney from Evercore ISI maintained a Buy rating on Amazon, with a price target of $280.00. The company's shares closed last Friday at $214.75. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. According to TipRanks, Mahaney is a 5-star analyst with an average return of 14.3% and a 58.16% success rate. Mahaney covers the Communication Services sector, focusing on stocks such as Alphabet Class A, Meta Platforms, and Netflix. In addition to Evercore ISI, Amazon also received a Buy from TR | OpenAI – 4o's Rina Curatex in a report issued yesterday. However, on August 1, Wells Fargo reiterated a Hold rating on Amazon (NASDAQ: AMZN).
Yahoo
5 hours ago
- Yahoo
LifeMD to Participate in the Canaccord Genuity 45th Annual Growth Conference
NEW YORK, Aug. 04, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced its participation in the Canaccord Genuity 45th Annual Growth Conference, which will be held August 12-14, 2025 at the InterContinental Boston. Management will participate in a fireside chat on Wednesday, August 13th at 8:30 a.m. Eastern time and will hold one-on-one meetings with investors on August 12-13. Investors can register for the conference by contacting their Canaccord Genuity representative. About LifeMD, Inc. LifeMD® is a leading provider of virtual primary care. LifeMD offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men's and women's health, weight management, and hormone therapy. The Company leverages a vertically integrated, proprietary digital care platform, a 50-state affiliated medical group, a state-of-the-art affiliated pharmacy, and a U.S.-based patient care center to increase access to high-quality and affordable care. For more information, please visit Investor ContactMarc Benathen, Chief Financial Officermarc@ Media Contact Jessica Friedeman, Chief Marketing Officerpress@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
